Medwork and Fujifilm have been collaborating since 2012. With technologically innovative endoscopic systems and a global sales network, Fujifilm operates worldwide and, through this acquisition, can offer a nearly complete product portfolio in endoscopy as a system supplier and one-stop shop.
Based in Höchstadt, Bavaria/Germany, Medwork GmbH has been active in the medical technology field for over 20 years and employs approximately 140 staff members.
Medwork develops and manufactures medical instruments for therapeutic endoscopy in the field of gastroenterology, primarily used in gastroscopy and colonoscopy procedures.
Medwork's business has shown positive growth: Gross profit increased from approximately €9 million in 2013 to over €10 million in 2015 and nearly €13 million in 2017. This led to a net income of €2.2 million and an EBITDA of approximately €4 million in 2017.
The Japanese company Fujifilm is listed on the Nikkei 225. In 2018, Fujifilm generated revenues of ¥2433 billion (approximately €20 billion) and employs nearly 80,000 people.
Founded in 1934 with the production of motion picture film, the company has evolved into a global technology conglomerate through a strong focus on research and development, operating in various business sectors. Fujifilm is widely recognized for its contributions to the fields of photography and film.
In medical technology, Fujifilm Medical Systems provides complete systems covering digital imaging and hospital-wide image distribution. In addition to the traditional PACS for hospitals and clinics, AXON PACS is offered as an archival solution for small to mid-sized practices or practice groups. The "Medical Systems" division also includes solutions in digital radiography, where Fujifilm is regarded as the inventor and market leader.
In the Life Science segment, Fujifilm offers fluorescence scanners, CCD camera systems for bio-imaging, digital autoradiography, QuickGene nucleic acid extraction systems for molecular diagnostics and forensics, and Clinical Chemistry Analyzers (Fuji Dri-Chem). As part of its 2006 strategic shift, this area was designated a core business.
In early 2008, Fujifilm announced the acquisition of pharmaceutical manufacturer Toyama, marking its expansion into a "healthcare" company. The goal was to triple revenues in the medical sector over the next decade, covering the spectrum from medical prevention to diagnosis and therapy. Previously, the company had acquired Daiichi Radioisotope Laboratories Ltd., integrating it as Fujifilm RI Pharma, which signaled its entry into nuclear medical imaging diagnostics and therapeutic radiopharmaceuticals. In early 2007, the acquisition of the American company Problem Solving Concepts Inc. enabled the integration of cardiology into Fujifilm's PACS system.
On December 15, 2011, Fujifilm announced the acquisition of Sonosite, a specialist in portable medical ultrasound diagnostic systems.
ConAlliance is a leading consulting firm specializing in Mergers & Acquisitions (M&A) and Corporate Finance within the healthcare and life sciences sectors. The company offers comprehensive services, including business sales and acquisitions, due diligence, business valuations, and market analysis. With a global network and deep industry expertise, ConAlliance supports its clients in complex transactions and strategic projects. Their holistic approach and focus on the healthcare industry enable the development of tailored solutions for hospitals, pharmaceutical companies, medical technology firms, and other healthcare providers.
For further information, please contact us.